Page 305 - Read Online

Page 18 of 18 Zimmermann et al. Vessel Plus 2019;3:31 I http://dx.doi.org/10.20517/2574-1209.2019.010

120. Kimura M, Tamura Y, Takei M, Yamamoto T, Ono T, et al. Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary
arterial hypertension: a pilot study. BMC Pulm Med 2015;15:62.
121. Li Q, Dimopoulos K, Zhang C, Zhu Y, Liu Q, et al. Acute effect of Inhaled Iloprost in children with pulmonary arterial hypertension
associated with simple congenital heart defects. Pediatr Cardiol 2018;39:757-62.
122. Brida M, Gatzoulis MA. Pulmonary arterial hypertension in adult congenital heart disease. Heart 2018;104:1568-74.
123. Bradley EA, Chakinala M, Billadello JJ. Usefulness of medical therapy for pulmonary hypertension and delayed atrial septal defect
closure. Am J Cardiol 2013;112:1471-6.
124. Jalal Z, Hascoet S, Baruteau AE, Iriart X, Kreitmann B, et al. Long-term complications after transcatheter atrial septal defect closure: a
review of the medical literature. Can J Cardiol 2016;32:1315 e11-8.
125. Mallula K, Amin Z. Recent changes in instructions for use for the Amplatzer atrial septal defect occluder: how to incorporate these
changes while using transesophageal echocardiography or intracardiac echocardiography? Pediatr Cardiol 2012;33:995-1000.
126. Amin Z. Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement. Catheter Cardiovasc Interv
2014;83:84-92.
127. Jung SY, Choi JY. Transcatheter closure of atrial septal defect: principles and available devices. J Thorac Dis 2018;10:S2909-22.
128. McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z. Relative risk factors for cardiac erosion following transcatheter
closure of atrial septal defects: a case-control study. Circulation 2016;133:1738-46.
129. Narin N, Baykan A, Argun M, Ozyurt A, Pamukcu O, et al. New modified balloon-assisted technique to provide appropriate deployment
in the closure of large secundum atrial septal defect using amplatzer septal occluder in children. J Invasive Cardiol 2014;26:597-602.
130. Al-Qbandi MH, Al-Bannai OA, Behbehani FQ. Steerable atrial septal occluder implantation device with flexible neck. United States;
2010.
131. Yucel IK, Balli S, Kucuk M, Celebi A. Use of steerable delivery catheter to successfully deliver a Ceraflex septal occluder to close an
atrial septal defect in a child with interrupted inferior vena cava with azygos continuation. Turk Kardiyol Dern Ars 2016;44:244-7.
132. Kudumula V, Stumper O, Noonan P, Mehta C, De Giovanni J, et al. Transcatheter retrieval of cardiovascular foreign bodies in children:
a 15-year single centre experience. Pediatr Cardiol 2017;38:1183-90.
133. Herbert JT, Kertai MD. Transesophageal echocardiography use in diagnosis and management of embolized intravascular foreign bodies.
Semin Cardiothorac Vasc Anesth 2018;22:100-3.
134. Shebani SO, Rehman R, Taliotis D, Magee A, Hayes NJ, et al. Techniques for transcatheter retrieval of the occlutech ASD device United
Kingdom-European multicenter report. Catheter Cardiovasc Interv 2017;89:690-8.
135. Durmuş G, Kalyoncuoğlu M, Belen E, Can MM. Retrieval of Embolized Atrial Septal Defect Closure Device in the Left Iliac Artery.
Am J Cardiol 2018;121:e156.
136. Crawford DA, Naidu SG, Shah AA, Davila VJ, Stone WM. Endovascular retrieval of an embolized atrial septal occluder device from
the abdominal aorta. Vasc Endovascular Surg 2018;52:669-73.
137. Martins DS, Mendes IC, Silva JR, Anjos R. Retrieval techniques. Atlas of Cardiac Catheterization for Congenital Heart Disease.
Springer; 2019. pp. 281-9.
138. Pavithran S, Sivakumar K. A novel snare assistance safeguards against early embolization of devices and facilitates quick retrieval of
malpositioned devices in atrial septal defects with deficient margins. Ann Pediatr Cardiol 2015;8:189-95.
139. Bhattacharyya S, Ilsley CD, Baltabaeva A. Disintegration of polyvinyl alcohol membrane covering atrial septal defect closure device.
Eur Heart J Cardiovasc Imaging 2015;16:1153.
140. Teekakirikul P, Zhu W, Xu X, Smith AM, Wang C, et al. Identification of a novel sarcomeric TPM1 variant in familial atrial septal
defect. Circulation 2018;138:A15276.
141. Su W, Wang RC, Lohano MK, Wang L, Zhu P, et al. Identification of two mutations in PCDHGA4 and SLFN14 genes in an atrial septal
defect family. Curr Med Sci 2018;38:989-96.
142. Wang J, Luo J, Chen Q, Wang X, He J, et al. Identification of LBX2 as a novel causal gene of atrial septal defect. Int J cardiol
2018;265:188-94.
143. DeLaughter DM, Bick AG, Wakimoto H, McKean D, Gorham JM, et al. Single-cell resolution of temporal gene expression during heart
development. Dev Cell 2016;39:480-90.
144. Bulatovic I, Mansson-Broberg A, Sylven C, Grinnemo KH. Human fetal cardiac progenitors: the role of stem cells and progenitors in
the fetal and adult heart. Best Pract Res Clin Obstet Gynaecol 2016;31:58-68.
145. Hameed A, Duffy GP, Hasan B, Fatimi SH. Tissue engineered solutions for intracardiac septal defects: a large step forward in an unmet
clinical need. Ann Surg 2017;265:e11-2.
146. Lang N, Pereira MJ, Lee Y, Friehs I, Vasilyev NV, et al. A blood-resistant surgical glue for minimally invasive repair of vessels and
heart defects. Sci Transl Med 2014;6:218ra6.
147. Tang B, Su F, Sun X, Wu Q, Xing Q, et al. Recent development of transcatheter closure of atrial septal defect and patent foramen ovale
with occluders. J Biomed Mater Res B Appl Biomater 2018;106:433-43.
148. Sun Y, Zhang X, Li W, Di Y, Xing Q, et al. 3D printing and biocompatibility study of a new biodegradable occluder for cardiac defect. J
Cardiol 2019; doi: 10.1016/j.jjcc.2019.02.002.